https://orcid.org/0000-0001-7111-9891
References
- Muthukumaraswamy S, Forsyth A, Lumley T. Blinding and expectancy confounds in psychedelic randomised controlled trials. Expert Rev Clin Pharmacol. 2021. DOI:https://doi.org/10.1080/17512433.2021.1933434
- Bello S, Moustgaard H, Hróbjartsson A. Unreported formal assessment of unblinding occurred in 4 of 10 randomized clinical trials, unreported loss of blinding in 1 of 10 trials. J Clin Epidemiol. 2017;81:42–50.
- Bello S, Moustgaard H, Hróbjartsson A. The risk of unblinding was infrequently and incompletely reported in 300 randomized clinical trial publications. J Clin Epidemiol. 2014;67(10):1059–1069.
- Mitchell JM, Bogenschutz M, Lilienstein A, et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat Med. 2021;27(6):1025–1033.
- Oehen P, Traber R, Widmer V, et al. A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD). J Psychopharmacol. 2013;27(1):40–52.
- Berrios, G., & Marková, I. Toward a new epistemology of psychiatry. In: Kirmayer L, Lemelson R, Cummings C, editors. Re-visioning psychiatry: cultural phenomenology, critical neuroscience, and global mental health. Cambridge: Cambridge University Press; 2015. p. 41-64. DOI:https://doi.org/10.1017/CBO9781139424745.005.
- Downing NS, Shah ND, Aminawung JA, et al. Postmarket safety events among novel therapeutics approved by the US food and drug administration between 2001 and 2010. JAMA. 2017;317(18):1854–1863.
- Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391(10128):1357–1366.
- Dyck E. Psychedelic Psychiatry : LSD from Clinic to Campus / Erika Dyck. Baltimore, Md: Johns Hopkins University Press; 2008. Print.
- Mills JA. Hallucinogens as hard science: the adrenochrome hypothesis for the biogenesis of schizophrenia. Hist Psychol. 2010;13(2):178–195.
- Oram M. Efficacy and enlightenment: LSD psychotherapy and the drug amendments of 1962. J Hist Med Allied Sci. 2014;69(2):221–250.
- Dumas-Mallet E, Gonon F. Messaging in biological psychiatry: misrepresentations, their causes, and potential consequences. Harv Rev Psychiatry. 2020;28(6):395–403.
- Nutt D, Bazire S, Phillips LD, et al. So near yet so far: why won’t the UK prescribe medical cannabis? BMJ Open. 2020;10(9):e038687.
- Schenberg EE, Gerber K. Overcoming epistemic injustices in the biomedical study of Ayahuasca: towards ethical and sustainable regulation. Transcult Psychiatry. 2021 (in press).
- Schenberg EE. Psychedelic-assisted psychotherapy: a paradigm shift in psychiatric research and development. Front Pharmacol. 2018;9:733.